“Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 – Type I Interferon Pathway”. 2022. Cardiology and Cardiovascular Medicine 6 (4): 416-23. https://fortunejournals.org/ojs/index.php/ccm/article/view/16285.